Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 76

1.

Rapid Clearance Profile of Plasma Circulating Tumor HPV Type 16 DNA during Chemoradiotherapy Correlates with Disease Control in HPV-Associated Oropharyngeal Cancer.

Chera BS, Kumar S, Beaty BT, Marron D, Jefferys S, Green R, Goldman EC, Amdur R, Sheets N, Dagan R, Hayes DN, Weiss J, Grilley-Olson JE, Zanation A, Hackman T, Blumberg JM, Patel S, Weissler M, Tan XM, Parker JS, Mendenhall W, Gupta GP.

Clin Cancer Res. 2019 May 14. doi: 10.1158/1078-0432.CCR-19-0211. [Epub ahead of print]

PMID:
31088830
2.

A Prospective Analysis of Radiation Oncologist Compliance With Early Peer Review Recommendations.

Walburn T, Wang K, Sud S, Zakrzewski A, Roehm R, Sutton S, Tan X, Adams R, Mazur L, Marks LB, Chera BS.

Int J Radiat Oncol Biol Phys. 2019 Jul 1;104(3):494-500. doi: 10.1016/j.ijrobp.2019.02.036. Epub 2019 Feb 23.

PMID:
30807823
3.

Regarding "patient-reported versus physiologic swallowing outcomes in patients with head and neck cancer after chemoradiation".

Amdur RJ, Chera BS.

Laryngoscope. 2019 May;129(5):E169. doi: 10.1002/lary.27862. Epub 2019 Feb 13. No abstract available.

PMID:
30761549
4.

Shoulder symptoms and quality of life impact of limited neck dissection after de-intensified chemoradiotherapy: Secondary analysis of two prospective trials.

Wang K, Moon DH, Amdur RJ, Dagan R, Sheets NC, Shen CJ, Green R, Patel SN, Zanation AM, Thorp BD, Hackman TG, Weissler MC, Mendenhall WM, Chera BS.

Head Neck. 2019 May;41(5):1213-1219. doi: 10.1002/hed.25535. Epub 2018 Dec 15.

PMID:
30554453
5.

Assessment of Risk of Xerostomia After Whole-Brain Radiation Therapy and Association With Parotid Dose.

Wang K, Pearlstein KA, Moon DH, Mahbooba ZM, Deal AM, Wang Y, Sutton SR, Motley BB, Judy GD, Holmes JA, Sheets NC, Kasibhatla MS, Pacholke HD, Shen CJ, Zagar TM, Marks LB, Chera BS.

JAMA Oncol. 2018 Nov 29. doi: 10.1001/jamaoncol.2018.4951. [Epub ahead of print]

PMID:
30489607
6.

Quality of Life for Patients With Favorable-Risk HPV-Associated Oropharyngeal Cancer After De-intensified Chemoradiotherapy.

Pearlstein KA, Wang K, Amdur RJ, Shen CJ, Dagan R, Weiss J, Grilley-Olson JE, Zanation A, Hackman TG, Thorp BD, Blumberg JM, Patel S, Sheets N, Weissler MC, Mendenhall WM, Chera BS.

Int J Radiat Oncol Biol Phys. 2019 Mar 1;103(3):646-653. doi: 10.1016/j.ijrobp.2018.10.033. Epub 2018 Nov 2.

PMID:
30395903
7.

Preservation of swallowing function with de-intensified chemoradiation therapy for HPV-associated oropharyngeal squamous cell carcinoma.

Judy GD, Green R, Aumer SL, Amdur RJ, Tan X, Sheets N, Weissler M, Zanation A, Patel S, Hackman T, Mendenhall WM, Chera BS.

Adv Radiat Oncol. 2018 Mar 14;3(3):356-365. doi: 10.1016/j.adro.2018.03.002. eCollection 2018 Jul-Sep.

8.

Misuse of Quality of Life Evaluation in Oncology Studies: Reification, Adaptation, and the U-Shaped Curve.

Amdur RJ, Chera BS.

Pract Radiat Oncol. 2018 May 16. pii: S1879-8500(18)30148-6. doi: 10.1016/j.prro.2018.05.002. [Epub ahead of print] No abstract available.

PMID:
29907513
9.

Clinician-observed and patient-reported toxicities and their association with poor tolerance to therapy in older patients with head and neck or lung cancer treated with curative radiotherapy.

Moon DH, Chera BS, Deal AM, Wang Y, Muss HB, VanderWalde NA.

J Geriatr Oncol. 2019 Jan;10(1):42-47. doi: 10.1016/j.jgo.2018.05.016. Epub 2018 Jun 11.

PMID:
29903673
10.

Phase 2 trial of neoadjuvant chemotherapy and transoral endoscopic surgery with risk-adapted adjuvant therapy for squamous cell carcinoma of the head and neck.

Weiss JM, Grilley-Olson JE, Deal AM, Zevallos JP, Chera BS, Paul J, Knowles MF, Usenko D, Weissler MC, Patel S, Hayes DN, Hackman T.

Cancer. 2018 Jul 15;124(14):2986-2992. doi: 10.1002/cncr.31526. Epub 2018 May 9.

PMID:
29741773
11.

Mature results of a prospective study of deintensified chemoradiotherapy for low-risk human papillomavirus-associated oropharyngeal squamous cell carcinoma.

Chera BS, Amdur RJ, Tepper JE, Tan X, Weiss J, Grilley-Olson JE, Hayes DN, Zanation A, Hackman TG, Patel S, Sheets N, Weissler MC, Mendenhall WM.

Cancer. 2018 Jun 1;124(11):2347-2354. doi: 10.1002/cncr.31338. Epub 2018 Mar 26.

12.

Multivalent Binding and Biomimetic Cell Rolling Improves the Sensitivity and Specificity of Circulating Tumor Cell Capture.

Myung JH, Eblan MJ, Caster JM, Park SJ, Poellmann MJ, Wang K, Tam KA, Miller SM, Shen C, Chen RC, Zhang T, Tepper JE, Chera BS, Wang AZ, Hong S.

Clin Cancer Res. 2018 Jun 1;24(11):2539-2547. doi: 10.1158/1078-0432.CCR-17-3078. Epub 2018 Mar 15.

13.

Pitfalls of post-treatment PET after de-intensified chemoradiotherapy for HPV-associated oropharynx cancer: Secondary analysis of a phase 2 trial.

Wang K, Wong TZ, Amdur RJ, Mendenhall WM, Sheets NC, Green R, Thorp BD, Patel SN, Hackman TG, Zanation AM, Weissler MC, Chera BS.

Oral Oncol. 2018 Mar;78:108-113. doi: 10.1016/j.oraloncology.2018.01.023. Epub 2018 Feb 20.

PMID:
29496037
14.

Personalized Medicine Versus Quality: Contradictory or Mutually Dependent?

Marks LB, Mazur LM, Chera BS, Hertz CM.

Int J Radiat Oncol Biol Phys. 2018 Jun 1;101(2):271-273. doi: 10.1016/j.ijrobp.2017.05.041. Epub 2017 Jun 6. No abstract available.

PMID:
29325811
15.

Current Status and Future Directions of Treatment Deintensification in Human Papilloma Virus-associated Oropharyngeal Squamous Cell Carcinoma.

Chera BS, Amdur RJ.

Semin Radiat Oncol. 2018 Jan;28(1):27-34. doi: 10.1016/j.semradonc.2017.08.001. Review.

PMID:
29173753
16.

Assessment of PlanIQ Feasibility DVH for head and neck treatment planning.

Fried DV, Chera BS, Das SK.

J Appl Clin Med Phys. 2017 Sep;18(5):245-250. doi: 10.1002/acm2.12165. Epub 2017 Aug 30.

17.

Incidence of, and risk factors for, mandibular osteoradionecrosis in patients with oral cavity and oropharynx cancers.

Moon DH, Moon SH, Wang K, Weissler MC, Hackman TG, Zanation AM, Thorp BD, Patel SN, Zevallos JP, Marks LB, Chera BS.

Oral Oncol. 2017 Sep;72:98-103. doi: 10.1016/j.oraloncology.2017.07.014. Epub 2017 Jul 16.

PMID:
28797468
18.

Dosimetric Predictors of Patient-Reported Xerostomia and Dysphagia With Deintensified Chemoradiation Therapy for HPV-Associated Oropharyngeal Squamous Cell Carcinoma.

Chera BS, Fried D, Price A, Amdur RJ, Mendenhall W, Lu C, Das S, Sheets N, Marks L, Mavroidis P.

Int J Radiat Oncol Biol Phys. 2017 Aug 1;98(5):1022-1027. doi: 10.1016/j.ijrobp.2017.03.034. Epub 2017 Mar 27.

PMID:
28721884
19.

Identifying Factors and Root Causes Associated With Near-Miss or Safety Incidents in Patients Treated With Radiotherapy: A Case-Control Analysis.

Judy GD, Mosaly PR, Mazur LM, Tracton G, Marks LB, Chera BS.

J Oncol Pract. 2017 Aug;13(8):e683-e693. doi: 10.1200/JOP.2017.021121. Epub 2017 Jun 26.

PMID:
28650743
20.

Reducing Unplanned Admissions: Focusing on Hospital Admissions and Emergency Department Visits for Patients With Head and Neck Cancer During Radiation Therapy
.

Terzo L, Fleming M, Yechoor A, Camporeale J, Troxler M, Roth E, Tan X, Pignone M, Marks L, Chera BS.

Clin J Oncol Nurs. 2017 Jun 1;21(3):363-369. doi: 10.1188/17.CJON.363-369.

PMID:
28524888
21.

Improving radiation oncology providers' workload and performance: Can simulation-based training help?

Mazur LM, Mosaly PR, Tracton G, Stiegler MP, Adams RD, Chera BS, Marks LB.

Pract Radiat Oncol. 2017 Sep - Oct;7(5):e309-e316. doi: 10.1016/j.prro.2017.02.005. Epub 2017 Feb 17.

PMID:
28462896
22.

The incidence of radiation necrosis following stereotactic radiotherapy for melanoma brain metastases: the potential impact of immunotherapy.

Kaidar-Person O, Zagar TM, Deal A, Moschos SJ, Ewend MG, Sasaki-Adams D, Lee CB, Collichio FA, Fried D, Marks LB, Chera BS.

Anticancer Drugs. 2017 Jul;28(6):669-675. doi: 10.1097/CAD.0000000000000497.

PMID:
28368903
23.

Beware of deintensification of radiation therapy in patients with p16-positive oropharynx cancer and rheumatological diseases.

Chera BS, Amdur RJ, Mendenhall W, Zevallos J, Hayes DN.

Pract Radiat Oncol. 2017 Jul - Aug;7(4):e261-e262. doi: 10.1016/j.prro.2016.12.004. Epub 2016 Dec 16. No abstract available.

PMID:
28242189
24.

Evaluation of PET/MRI for Tumor Volume Delineation for Head and Neck Cancer.

Wang K, Mullins BT, Falchook AD, Lian J, He K, Shen D, Dance M, Lin W, Sills TM, Das SK, Huang BY, Chera BS.

Front Oncol. 2017 Jan 23;7:8. doi: 10.3389/fonc.2017.00008. eCollection 2017.

25.

The Role of Radiation Therapy in the Management of Sinonasal and Ventral Skull Base Malignancies.

Wang K, Zanation AM, Chera BS.

Otolaryngol Clin North Am. 2017 Apr;50(2):419-432. doi: 10.1016/j.otc.2016.12.014. Epub 2017 Jan 16. Review.

PMID:
28104274
26.

Estimating the excess lifetime risk of radiation induced secondary malignancy (SMN) in pediatric patients treated with craniospinal irradiation (CSI): Conventional radiation therapy versus helical intensity modulated radiation therapy.

Holmes JA, Chera BS, Brenner DJ, Shuryak I, Wilson AK, Lehman-Davis M, Fried DV, Somasundaram V, Lian J, Cullip T, Marks LB.

Pract Radiat Oncol. 2017 Jan - Feb;7(1):35-41. doi: 10.1016/j.prro.2016.07.002. Epub 2016 Jul 8.

PMID:
27663930
27.

Protons for Oropharyngeal Cancer Have Not Yet Justified Their Promise.

Beitler JJ, Chera BS.

Int J Radiat Oncol Biol Phys. 2016 Jul 15;95(4):1115-6. doi: 10.1016/j.ijrobp.2016.03.028. No abstract available.

PMID:
27354126
28.

Creating a Culture of Safety Within an Institution: Walking the Walk.

Chera BS, Mazur L, Adams RD, Kim HJ, Milowsky MI, Marks LB.

J Oncol Pract. 2016 Oct;12(10):880-883. No abstract available.

PMID:
27328790
29.

Impact of post-chemoradiotherapy superselective/selective neck dissection on patient reported quality of life.

Wang K, Amdur RJ, Mendenhall WM, Green R, Aumer S, Hackman TG, Zanation AM, Zevallos JP, Patel SN, Weissler MC, Chera BS.

Oral Oncol. 2016 Jul;58:21-6. doi: 10.1016/j.oraloncology.2016.04.015. Epub 2016 May 14.

PMID:
27311398
30.

How Can We Effect Culture Change Toward Data-Driven Medicine?

Mayo CS, Deasy JO, Chera BS, Freymann J, Kirby JS, Hardenberg PH.

Int J Radiat Oncol Biol Phys. 2016 Jul 1;95(3):916-921. doi: 10.1016/j.ijrobp.2015.12.355. Epub 2015 Dec 21. No abstract available.

PMID:
27302507
31.

Comparison of Patient- and Practitioner-Reported Toxic Effects Associated With Chemoradiotherapy for Head and Neck Cancer.

Falchook AD, Green R, Knowles ME, Amdur RJ, Mendenhall W, Hayes DN, Grilley-Olson JE, Weiss J, Reeve BB, Mitchell SA, Basch EM, Chera BS.

JAMA Otolaryngol Head Neck Surg. 2016 Jun 1;142(6):517-23. doi: 10.1001/jamaoto.2016.0656.

32.

Toward a better understanding of task demands, workload, and performance during physician-computer interactions.

Mazur LM, Mosaly PR, Moore C, Comitz E, Yu F, Falchook AD, Eblan MJ, Hoyle LM, Tracton G, Chera BS, Marks LB.

J Am Med Inform Assoc. 2016 Nov;23(6):1113-1120. doi: 10.1093/jamia/ocw016. Epub 2016 Mar 28.

PMID:
27026617
33.

Use of mobile device technology to continuously collect patient-reported symptoms during radiation therapy for head and neck cancer: A prospective feasibility study.

Falchook AD, Tracton G, Stravers L, Fleming ME, Snavely AC, Noe JF, Hayes DN, Grilley-Olson JE, Weiss JM, Reeve BB, Basch EM, Chera BS.

Adv Radiat Oncol. 2016 Feb 18;1(2):115-121. doi: 10.1016/j.adro.2016.02.001. eCollection 2016 Apr-Jun.

34.

The Promise and Burden of Peer Review in Radiation Oncology.

Chera BS, Mazur L, Adams RD, Marks LB.

J Oncol Pract. 2016 Mar;12(3):196-8. doi: 10.1200/JOP.2015.008961. Epub 2016 Feb 2. No abstract available.

PMID:
26837564
35.

Phase 2 Trial of De-intensified Chemoradiation Therapy for Favorable-Risk Human Papillomavirus-Associated Oropharyngeal Squamous Cell Carcinoma.

Chera BS, Amdur RJ, Tepper J, Qaqish B, Green R, Aumer SL, Hayes N, Weiss J, Grilley-Olson J, Zanation A, Hackman T, Funkhouser W, Sheets N, Weissler M, Mendenhall W.

Int J Radiat Oncol Biol Phys. 2015 Dec 1;93(5):976-85. doi: 10.1016/j.ijrobp.2015.08.033. Epub 2015 Aug 22.

PMID:
26581135
36.

Integrating Patient-Reported Outcome Measures into Routine Cancer Care: Cancer Patients' and Clinicians' Perceptions of Acceptability and Value.

Stover A, Irwin DE, Chen RC, Chera BS, Mayer DK, Muss HB, Rosenstein DL, Shea TC, Wood WA, Lyons JC, Reeve BB.

EGEMS (Wash DC). 2015 Oct 29;3(1):1169. doi: 10.13063/2327-9214.1169. eCollection 2015.

37.

Applying Normal Accident Theory to radiation oncology: Failures are normal but patient harm can be prevented.

Chera BS, Mazur L, Marks LB.

Pract Radiat Oncol. 2015 Sep-Oct;5(5):325-327. doi: 10.1016/j.prro.2015.07.005. Epub 2015 Jul 26. No abstract available.

PMID:
26362707
38.

Improving Patient Safety in Clinical Oncology: Applying Lessons From Normal Accident Theory.

Chera BS, Mazur L, Buchanan I, Kim HJ, Rockwell J, Milowsky MI, Marks LB.

JAMA Oncol. 2015 Oct;1(7):958-64. doi: 10.1001/jamaoncol.2015.0891. Erratum in: JAMA Oncol. 2015 Oct;1(7):989.

PMID:
26182183
39.

Increased risk of salivary gland cancer among women with a previous cancer diagnosis.

Falchook AD, Zevallos JP, Chera BS.

Head Neck. 2016 Apr;38 Suppl 1:E446-51. doi: 10.1002/hed.24016. Epub 2015 Jul 14.

PMID:
25581457
40.

Postoperative radiotherapy for diffuse pigmented villonodular synovitis of the temporomandibular joint.

Joshi K, Huang B, Scanga L, Buchman C, Chera BS.

Am J Otolaryngol. 2015 Jan-Feb;36(1):106-13. doi: 10.1016/j.amjoto.2014.10.017. Epub 2014 Oct 16. Review. Erratum in: Am J Otolaryngol. 2015 Sep-Oct;36(5):725. Joshi, Kritikia [corrected to Joshi, Kritika].

PMID:
25459320
41.

Recommended patient-reported core set of symptoms to measure in head and neck cancer treatment trials.

Chera BS, Eisbruch A, Murphy BA, Ridge JA, Gavin P, Reeve BB, Bruner DW, Movsas B.

J Natl Cancer Inst. 2014 Jul 8;106(7). pii: dju127. doi: 10.1093/jnci/dju127. Print 2014 Jul. Review.

42.

Quantification of the impact of multifaceted initiatives intended to improve operational efficiency and the safety culture: a case study from an academic medical center radiation oncology department.

Chera BS, Mazur L, Jackson M, Taylor K, Mosaly P, Chang S, Deschesne K, LaChapelle D, Hoyle L, Saponaro P, Rockwell J, Adams R, Marks LB.

Pract Radiat Oncol. 2014 Mar-Apr;4(2):e101-e108. doi: 10.1016/j.prro.2013.05.007. Epub 2013 Jun 29.

PMID:
24890355
43.

Relating physician's workload with errors during radiation therapy planning.

Mazur LM, Mosaly PR, Hoyle LM, Jones EL, Chera BS, Marks LB.

Pract Radiat Oncol. 2014 Mar-Apr;4(2):71-75. doi: 10.1016/j.prro.2013.05.010. Epub 2013 Jul 17.

PMID:
24890346
44.

Positron emission tomography and stage migration in head and neck cancer.

VanderWalde NA, Salloum RG, Liu TL, Hornbrook MC, O'Keeffe Rosetti MC, Ritzwoller DP, Fishman PA, Elston Lafata J, Khandani AH, Chera BS.

JAMA Otolaryngol Head Neck Surg. 2014 Jul;140(7):654-61. doi: 10.1001/jamaoto.2014.812.

45.

Effectiveness of chemoradiation for head and neck cancer in an older patient population.

VanderWalde NA, Meyer AM, Deal AM, Layton JB, Liu H, Carpenter WR, Weissler MC, Hayes DN, Fleming ME, Chera BS.

Int J Radiat Oncol Biol Phys. 2014 May 1;89(1):30-7. doi: 10.1016/j.ijrobp.2014.01.053.

PMID:
24725687
46.

Quantifying the impact of cross coverage on physician's workload and performance in radiation oncology.

Mosaly PR, Mazur LM, Jones EL, Hoyle L, Zagar T, Chera BS, Marks LB.

Pract Radiat Oncol. 2013 Oct-Dec;3(4):e179-86. doi: 10.1016/j.prro.2013.02.007. Epub 2013 Apr 22.

PMID:
24674416
47.

Patterns of local failure for sinonasal malignancies.

Fried DV, Zanation AM, Huang B, Hayes N, Weissler M, Hackman T, Shores C, Rosenman J, Morris DE, Funkhouser W, Varia M, Chera BS.

Pract Radiat Oncol. 2013 Jul-Sep;3(3):e113-e120. doi: 10.1016/j.prro.2012.07.001. Epub 2012 Aug 9.

PMID:
24674372
48.

Modeling the dosimetry of organ-at-risk in head and neck IMRT planning: an intertechnique and interinstitutional study.

Lian J, Yuan L, Ge Y, Chera BS, Yoo DP, Chang S, Yin F, Wu QJ.

Med Phys. 2013 Dec;40(12):121704. doi: 10.1118/1.4828788.

49.

Two-year and lifetime cost-effectiveness of intensity modulated radiation therapy versus 3-dimensional conformal radiation therapy for head-and-neck cancer.

Kohler RE, Sheets NC, Wheeler SB, Nutting C, Hall E, Chera BS.

Int J Radiat Oncol Biol Phys. 2013 Nov 15;87(4):683-9. doi: 10.1016/j.ijrobp.2013.08.011.

PMID:
24138916
50.

Patterns of care in older patients with squamous cell carcinoma of the head and neck: a surveillance, epidemiology, and end results-medicare analysis.

VanderWalde NA, Meyer AM, Liu H, Tyree SD, Zullig LL, Carpenter WR, Shores CD, Weissler MC, Hayes DN, Fleming M, Chera BS.

J Geriatr Oncol. 2013 Jul;4(3):262-70.

Supplemental Content

Loading ...
Support Center